Transdermal, Topical & Subcutaneous: Non-Invasive Delivery to Expand Product Line Extensions


Drug Development & Delivery
July/August 2012

The overall landscape of the transdermal, topical, and subcutaneous markets continue to evolve as non-invasive delivery of drugs to the skin or to the systemic circulation via the skin is a highly attractive proposition for many active drugs, be they poorly soluble or subject of first-pass metabolism when administered orally. Equally attractive is the possibility of administering chronic therapies via the skin, translating to convenience, safety, patience compliance, and drug efficacy.  This article discusses Adhesives Research’s skin-friendly, long-term wear adhesives for extended wear applications, and ARx, LLC’s technologies for transdermal, transmucosal, and soluble film products.

Read full article.